Home >> MARKETPLACE >> Thermo Fisher, Aesku sign distribution agreement

Thermo Fisher, Aesku sign distribution agreement

image_pdfCreate PDF

February 2024—Thermo Fisher Scientific announced an exclusive distribution agreement with Aesku Group to market, sell, and support Aesku’s portfolio of FDA-cleared immunofluorescence products, automated instruments, and software in the United States. The agreement expands Thermo Fisher’s immunology product portfolio of Elia autoimmune diagnostics, ImmunoCap allergy diagnostics, and Phadia systems to include complementary reagents and systems from Aesku.

Thermo Fisher Scientific, 800-955-6288
Aesku, +49 (6734) 9622-0

CAP TODAY
X